Effects of a Rhodiola rosea L. extract on acquisition and expression of morphine tolerance and dependence in mice

Journal of Psychopharmacology

Volumn 25, Issue 3, 2011, Pages 411-420

  Mattioli, Laura ^a   Perfumi, Marina ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

dependence; mice; morphine; Rhodiola rosea; tolerance; withdrawal

Indexed keywords

MORPHINE; NALOXONE; RHODIOLA ROSEA EXTRACT;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CLINICAL EVALUATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; INJECTION; MALE; MORPHINE ADDICTION; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST; WITHDRAWAL SYNDROME;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; MALE; MICE; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; PLANT EXTRACTS; RHODIOLA; TIME FACTORS;

EID: 79952138671     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109359096     Document Type: Article

References (77)

1. Abdel-Zaher AO, Hamdy MM, Aly SA, Abdel-Hady RH, Abdel-Rahman S. (2006) Attenuation of morphine tolerance and dependence by aminoguanidine in mice. Eur J Pharmacol 540: 60-66. (Pubitemid 43866689)
2. Abidov M., Crendal F., Grachev S., Seifulla R., Ziegenfuss T. (2003) Effect of extracts from Rhodiola rosea and Rhodiola crenulata (Crassulaceae) roots on ATP content in mitochondria of skeletal muscles. Bull Exp Biol Med 136: 585-587. (Pubitemid 39137285)
3. Ammon-Treiber S., Grecksch G., Stumm R., et al. (2004) Rapid, transient, and dose-dependent expression of hsp70 messenger RNA in the rat brain after morphine treatment. Cell Stress Chaperones 9: 182-197. (Pubitemid 39013814)
4. Asl BH, Hassanzadeh K., Khezri E., Mohammadi S. (2008) Evaluation of the effects of dextromethorphan and midazolam on morphine-induced tolerance and dependence in mice. Pak J Biol Sci 11: 1690-1695.
5. Ballantyne JC, Mao J. (2003) Opioid therapy for chronic pain. N Engl J Med 349: 1943-1953. (Pubitemid 37409712)
6. Barik J., Wonnacott S (2009) Molecular and cellular mechanisms of action of nicotine in the CNS. Handb Exp Pharmacol 192: 173-207.
7. Basso AM, Spina M., Rivier J., Vale W., Koob GF (1999) Corticotropin-releasing factor antagonist attenuates the ''anxiogenic-like'' effect in the defensive burying paradigm, but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology (Berl) 145: 21-30. (Pubitemid 29339759)
8. Bisaga A., Popik P. (2000) In search of a new pharmacological treatment of drug addiction: N-methyl-d-aspartate (NMDA) antagonists. Drug Alcohol Depend 59: 1-15. (Pubitemid 30116834)
9. Blum K., Chen TJ, Meshkin B., et al. (2007) Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behaviour, a subtype of Reward Deficiency Syndrome (RDS). is dependent upon gene polymorphisms: a hypothesis. Med Hypotheses 69: 1054-1060. (Pubitemid 47440164)
10. Brown RP, Gerbarg PL, Ramazanov Z. (2002) Rhodiola rosea. A Phytomedicinal Overview. Herbal Gram 56: 40-52.
11. Bryant CD, Zaki PA, Carroll FI, Evans CJ (2005) Opioids and addiction: emerging pharmaceutical strategies for reducing reward and opponent processes. Clin Neurosci Res 5: 103-115. (Pubitemid 41671139)
12. Cao LL, Du GH, Wang MW (2006) The effect of salidroside on cell damage induced by glutamate and intracellular free calcium in PC12 cells. J Asian Nat Prod Res 8: 159-165.
13. Cao L., Li T., Liu X. (2003) Association study of heroin dependence and catechol-o-methyltransferase gene. Chun-Hua I Hsueh I Chaun Hsueh Tsa Chih 20: 127-130. (Pubitemid 36427803)
14. Dhawan K. (2003) Drug/substance reversal effects of a novel tri-substituted benzoflavone moiety (BZF) isolated from Passiflora incarnata Linn. - a brief perspective. Addict Biol 8: 379-386. (Pubitemid 38102044)
15. DuPen A., Shen D., Ersek M. (2007) Mechanisms of opioid-induced tolerance and hyperalgesia. Pain Manag Nurs 8: 113-121.
16. Feily A., Abbasi N (2009) The inhibitory effect of Hypericum perforatum extract on morphine withdrawal syndrome in rat and comparison with clonidine. Phytother Res 23: 1549-1552.
17. Frenois F., Cador M., Caillé S., Stinus L., Le Moine C. (2002) Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci 16: 1377-1389. (Pubitemid 35340859)
18. Goeders NE (1997) A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology 22: 237-259. (Pubitemid 27305567)
19. Guo Y., Wang HL, Xiang XH, Zhao Y (2009) The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction. Neurosci Biobehav Rev 33: 864-873.
20. Gupta GL, Rana AC (2008) Effect of Withania somnifera Dunal in ethanol-induced anxiolysis and withdrawal anxiety in rats. Indian J Exp Biol 46: 470-475.
21. Harrison LM, Kastin AJ, Zadina JE (1998) Opiate tolerance and dependence: receptors, G-proteins, and antiopiates. Peptides 19: 1603-1630. (Pubitemid 29015903)
22. Heinrichs SC, Menzaghi F., Schulteis G., Koob GF, Stinus L. (1995) Suppression of corticotropin-releasing factor in the amygdale attenuates aversive consequences of morphine withdrawal. Behav Pharmacol 6: 74-80.
23. Inturrisi CE (2002) Clinical pharmacology of opioids for pain. Clin J Pain 18: S3 - S13.
24. Kasture S., Vinci S., Ibba F., et al. (2009) Withania somnifera prevents morphine withdrawal-induced decrease in spine density in nucleus accumbens shell of rats: a confocal laser scanning microscopy study. Neurotox Res 16: 343-355.
25. Kauhanen J., Hallikainen T., Tuomainen TP, et al. (2000) Association between the functional polymorphism of catechol-o-methyltransferase gene and alcohol consumption among social drinkers. Alcoholism Clin Exp Res 24: 135-139. (Pubitemid 30117413)
26. Kelley AE, Berridge KC (2002) The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 22: 3306-3311. (Pubitemid 37465733)
27. Kelly GS (2001) Rhodiola rosea: a possible plant adaptogen. Altern Med Rev 6: 293-302. (Pubitemid 32591865)
28. Kim HS, Jang CG, Oh KW, et al. (1998) Effects of ginseng total saponin on morphine-induced hyperactivity and conditioned place preference in mice. J Ethnopharmacol 60: 33-42.
29. Koob GF (2009) Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 56: 18-31.
30. Koob GF, Bloom FE (1985) Corticotropin-releasing factor and behaviour. Fed Proc 44: 259-263.
31. Koob GF, Le Moal M. (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278: 52-58. (Pubitemid 27446270)
32. Koob GF, Stinus L., Le Moal M., Bloom FE (1989) Opponent process theory of motivation: neurobiological evidence from studies of opiate dependence. Neurosci Biobehav Rev 13: 135-140. (Pubitemid 19241928)
33. Kurkin VA, Zapesochnaya GG (1986) Chemical composition and pharmacological properties of Rhodiola rosea. Khim Pharm Zurnal 20: 1231-1244.
34. Lazarova MB, Petkov VD, Markovska VL, Petkov VV, Mosharrof A. (1986) Effects of meclofenoxate and Extr. Rhodiolae roseae L. on electroconvulsive shock-impaired learning and memory in rats. Meth Find Exp Clin Pharmacol 8: 547-552. (Pubitemid 17208021)
35. Lee SY, Song DK, Jang CG (2003) Effects of Coptis japonica on morphine-induced conditioned place preference in mice. Arch Pharm Res 26: 540-544.
36. Lingford-Hughes A., Nutt D. (2003) Neurobiology of addiction and implications for treatment. Brit J Psychiatry 182: 97-100. (Pubitemid 36177229)
37. Linh PT, Kim YH, Hong SP, Jian JJ, Kang JS (2000) Quantitative determination of salidroside and tyrosol from the underground part of Rhodiola rosea by high performance liquid chromatography. Arch Pharm Res 23: 349-352.
38. Lishmanov IuB, Naumova AV, Afanas'ev SA, Maslov LN (1997) Contribution of the opioid system to realization of inotropic effects of Rhodiola rosea extracts in ischaemic and reperfusion heart damage in vitro. Eksp Klin Farmakol 60: 34-36.
39. Lu L., Grimm JW, Shaham Y., Hope BT (2003) Molecular neuroadaptations in the accumbens and ventral tegmental area during the first 90 days of forced abstinence from cocaine self-administration in rats. J Neurochem 85: 1604-1613. (Pubitemid 36702572)
40. Lu L., Liu Y., Zhu W., et al. (2009) Traditional medicine in the treatment of drug addiction. Am J Drug Alcohol Abuse 35: 1-11.
41. Mameskulova LA, Maslov LN, Lishmanov IuB, Krasnov EA (1997) The participation of the mu-, delta- and kappa-opioid receptors in the realization of the anti-arrhythmia effects of Rhodiola rosea. Eksp Klin Farmakol 60: 38-39.
42. Mattioli L., Funari C., Perfumi M (2009) Effects of Rhodiola rosea L. extract on behavioural and physiological alterations induced by chronic mild stress in female rats. J Psychopharmacol 23: 130-142.
43. Mattioli L., Perfumi M. (2007) Rhodiola rosea L. extract reduces stress-and CRF-induced anorexia in rats. J Psychopharmacol 21: 742-750. (Pubitemid 47437914)
44. Mattioli L., Perfumi M. (2009) Evaluation of Rhodiola rosea L. extract on affective and physical signs of nicotine withdrawal in mice. J Psychopharmacol in press. Nov 25. [Epub ahead of print].
45. Mercadante S. (1999) Opioid rotation for cancer pain: rationale and clinical aspects. Cancer 86: 1856-1866. (Pubitemid 29513057)
46. Milanes MV, Laorden ML (2000) Changes in catecholaminergic pathways innervating the rat heart ventricle during morphine dependence. Involvement of alpha(1). and alpha(2)-adrenoceptors. Eur J Pharmacol 397: 311-318. (Pubitemid 30323783)
47. Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2: 119-128. (Pubitemid 33673366)
48. Noda Y., Nabeshima T. (2004) Opiate physical dependence and N-methyl-D-aspartate receptors. Eur J Pharmacol 500: 121-128. (Pubitemid 39304002)
49. Olsson EMG, vonSchéele B., Panossian AG (2009) A randomized double-blind placebo controlled parallel group study of SHR-5 extract of Rhodiola rosea roots as treatment for patients with stress-related fatigue. Planta Med 75: 105-112.
50. Panossian A., Hambartsumyan M., Hovanissian A., Gabrielyan E., Wikman G. (2007) The adaptogens rhodiola and schizandra modify the response to immobilization stress in rabbits by suppressing the increase of phosphorylated stress activated protein kinase, nitricoxide and cortisol. Drug Targets Insights 1: 39-54.
51. Panossian A., Nikoyan N., Ohanyan N., et al. (2008) Comparative study of Rhodiola preparations on behavioural despair of rats. Phytomedicine 15: 84-91.
52. Panossian A., Wagner H. (2005) Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration. Phytother Res 19: 819-838. (Pubitemid 41670526)
53. Panossian A., Wikman G (2009) Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Curr Clin Pharmacol 4: 198-219.
54. Panossian A., Wikman G., Kaur P., Asea A (2009) Adaptogens exert a stress-protective effect by modulation of expression of molecular chaperones. Phytomedicine 16: 617-622.
55. Panossian A., Wikman G., Wagner H. (1999) Plant adaptogens. III. Earlier and more recent aspects and concepts on their mode of action. Phytomedicine 6: 287-300. (Pubitemid 129633202)
56. Papaleo F., Ghozland S., Ingallinesi M., Roberts AJ, Koob GF, Contarino A. (2008) Disruption of the CRF(2) receptor pathway decreases the somatic expression of opiate withdrawal. Neuropsychopharmacology 33: 2878-2887.
57. Papaleo F., Kitchener P., Contarino A. (2007) Disruption of the CRF/ CRF1 receptor stress system exacerbates the somatic signs of opiate withdrawal. Neuron 53: 577-589. (Pubitemid 46216753)
58. Pechnick RN (1993) Effects of opioids on the hypothalamopituitary-adrenal axis. Annu Rev Pharmacol Toxico 33: 353-382.
59. Perfumi M., Mattioli L. (2007) Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytother Res 21: 37-43. (Pubitemid 46173906)
60. Quattrocki E., Baird A., Yurgelun-Todd D. (2000) Biological aspects of the link between smoking and depression. Harv Rev Psychiatry 8: 99-110. (Pubitemid 30659210)
61. Ren X., Noda Y., Mamiya T., Nagai T., Nabeshima T. (2004) A neuroactive steroid, dehydroepiandrosterone sulphate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase. Behav Brain Res 152: 243-250. (Pubitemid 38757894)
62. Sahraei H., Fatemi SM, Pashaei-Rad S., Faghih-Monzavi Z., Salimi SH, Kamalinegad M. (2006) Effects of Papaver rhoeas extract on the acquisition and expression of morphine-induced conditioned place preference in mice. J Ethnopharmacol 103: 420-424. (Pubitemid 43143378)
63. Saratikov A., Marina TF, Fisanova LL (1978) Effect of golden root extract on processes of serotonin synthesis in the CNS. J Biol Sci 6: 142.
64. Sarnyai Z., Shaham Y., Heinrichs SC (2001) The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev 53: 209-244.
65. Schulteis G., Ahmed SH, Morse AC, Koob GF, Everitt BJ (2000) Conditioning and opiate withdrawal. Nature 405: 1013-1014. (Pubitemid 30447774)
66. Sharifzadeh M., Hadjiakhoondi A., Khanavi M., Susanabadi M. (2006) Effects of aqueous, methanolic and chloroform extracts of rhizome and aerial parts of Valeriana officinalis L. on naloxone-induced jumping in morphine-dependent mice. Addict Biol 11: 145-151. (Pubitemid 46696806)
67. Shevtsov VA, Zholus BI, Shervarly VI, et al. (2003) A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine 10: 95-105. (Pubitemid 36433202)
68. Spanagel R., Herz A., Shippenberg TS (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in-vivo microdialysis study. J Neurochem 55: 1734-1740.
69. Stancheva SL, Mosharrof A. (1987) Effect of the extract of Rhodiola rosea L. on the content of the brain biogenic monoamines. Med Physiol Comptes Rendus Acad Bulgare Sci 40: 85-87.
70. Stinus L., Cador M., Zorrilla EP, Koob GF (2005) Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Neuropsychopharmacology 30: 90-98. (Pubitemid 40024403)
71. Trujillo KA (2000) Are NMDA receptors involved in opiate-induced neural and behavioural plasticity? A review of preclinical studies. Psychopharmacology (Berl) 151: 121-141. (Pubitemid 30646416)
72. Uzbay I., Oglesby MW (2001) Nitric oxide and substance dependence. Neurosci Biobehav Rev 25: 43-52. (Pubitemid 32101388)
73. Vale W., Spiess J., Rivier C., Rivier J. (1981) Characterization of a 41-residue ovine hypothalamic peptide the stimulates secretion of corticotropin and beta-endorphin. Science 213: 1394-1397. (Pubitemid 12243637)
74. Van Diermen D., Marston A., Bravo J., Reist M., Carrupt PA, Hostettmann K (2009) Monoamine oxidase inhibition by Rhodiola rosea L. roots. J Ethnopharmacol 122: 397-401.
75. Wang S., You XT, Wang FP (1992) HPLC determination of salidroside in the roots of Rhodiola genus plants. Yao Xue Xue Pao 27: 849-852.
76. Wise RA (1988) The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol 97: 118-132.
77. Yoshikawa M., Shimada H., Shimoda H., Murakami N., Yamahara J., Matsuda H. (1996) Bioactive constituents of Chinese natural medicines. II. Rhodiolae radix. (1). Chemical structures and anti-allergic activity of rhodiocyanosides A and B from the underground part of Rhodiola quadrifida (Pal1.) Fisch. et Mey. (Crassulaceae) Chem Pharm Bull (Tokyo) 44: 2086-2091. (Pubitemid 26396758)